The Analyst Landscape: 5 Takes On Clarivate
Portfolio Pulse from Benzinga Insights
Clarivate (NYSE:CLVT) has received mixed analyst ratings over the past three months, with recent adjustments showing a decrease in the average 12-month price target from $9.50 to $8.6, a 9.47% drop. Analysts from Barclays, RBC Capital, and Oppenheimer have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Despite positive revenue growth of 1.81% for the quarter ending September 30, 2023, Clarivate faces challenges in market capitalization, net margin, ROE, and ROA, all below industry averages.
February 28, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Clarivate has seen a mix of analyst ratings, with a notable decrease in the average price target. Despite a positive revenue growth, the company struggles with profitability and efficiency metrics.
The decrease in the average price target by analysts, coupled with Clarivate's challenges in maintaining profitability and efficiency, suggests a potential short-term negative impact on its stock price. The mixed analyst ratings further contribute to the uncertainty around the stock's future performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100